85% of participants Achieved an A1c of less than 7% Lost up to 10.6 kg (23.3 lbs) Improvements seen in 52 weeks Trial #5 Compared tirzepatide with placebo added to titrated insulin Glargine with or without metformin
SUMMIT Trial Study Group, Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V et al (2025) Tirzepatide for heart failure with preserved ejection fraction and obesity
Since I was already comfortable with multiple daily injections from other peptide protocols, I wanted to see if splitting the dose made a noticeable difference
Sin embargo, es importante tener en cuenta que, a pesar de su popularidad, no existen pruebas cientficas slidas que demuestren su eficacia
Andrew Huberman: This is from a blood draw
GLP-1 Receptor Agonist Market Overview by Application Segment 9.1.1